Trial Profile
A Phase I, Double-Blind, Randomised, Placebo Controlled, Multiple-Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DS-1971a in Healthy Male and Female Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Feb 2024
Price :
$35
*
At a glance
- Drugs DS-1971 (Primary)
- Indications Pain
- Focus Adverse reactions
- Sponsors Daiichi Sankyo Inc
- 12 Feb 2016 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 06 Oct 2015 New trial record